236 related articles for article (PubMed ID: 30935088)
1. Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Wysocka A; Cybulski M; P Wysokiński A; Berbeć H; Stążka J; Zapolski T
J Clin Med; 2019 Mar; 8(4):. PubMed ID: 30935088
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Daniluk J; Zapolski T
BMC Cardiovasc Disord; 2017 Apr; 17(1):92. PubMed ID: 28376720
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
5. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 status in the Thai population.
Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
[TBL] [Abstract][Full Text] [Related]
7. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
10. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
11. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease.
Mackness B; Turkie W; Mackness M
Arch Med Sci; 2013 Feb; 9(1):8-13. PubMed ID: 23515649
[TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
14. The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase Activity.
Oniki K; Ohura K; Endo M; Akatwijuka D; Matsumoto E; Nakamura T; Ogata Y; Yoshida M; Harada-Shiba M; Saruwatari J; Ogura M; Imai T
J Atheroscler Thromb; 2024 Mar; ():. PubMed ID: 38508740
[TBL] [Abstract][Full Text] [Related]
15. Effect of pomegranate juice on paraoxonase enzyme activity in patients with type 2 diabetes.
Parsaeyan N; Mozaffari-Khosravi H; Mozayan MR
J Diabetes Metab Disord; 2012 Aug; 11(1):11. PubMed ID: 23497651
[TBL] [Abstract][Full Text] [Related]
16. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease.
MacKness B; Mackness MI; Durrington PN; Arrol S; Evans AE; McMaster D; Ferrières J; Ruidavets JB; Williams NR; Howard AN
Eur J Clin Invest; 2000 Jan; 30(1):4-10. PubMed ID: 10619995
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
Mackness B; Davies GK; Turkie W; Lee E; Roberts DH; Hill E; Roberts C; Durrington PN; Mackness MI
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1451-7. PubMed ID: 11557671
[TBL] [Abstract][Full Text] [Related]
19. Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients.
Chawhan SS; Mogarekar MR; Wagh RV; Das RR; Pramanik SS; Sonune SM; Chawhan SM
J Clin Diagn Res; 2015 Nov; 9(11):BC01-3. PubMed ID: 26673997
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Zapolski T
Med Sci Monit; 2014 Apr; 20():594-600. PubMed ID: 24721823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
